Showing results (1511-1520 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|May 23, 1998
On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpointsD TuJournal of Biopharmaceutical Statistics|May 23, 1998
Power considerations when a continuous outcome variable is dichotomizedB A Deyi, A S Kosinski, S M SnapinnJournal of Biopharmaceutical Statistics|August 26, 2025
Application of marginal structural models for causal inference on the treatment effect for overall survival in randomized controlled trials with control arm patients switching to active intervention after disease progressionJing Xu, Camden Bay, Bingxia Wang, et al.Journal of Biopharmaceutical Statistics|March 29, 2023
A confirmatory basket design considering non-inferiority and superiority testingYaohua Zhang, Chenghao Chu, Robert A Beckman, et al.Journal of Biopharmaceutical Statistics|June 5, 2014
Power and sample size for randomized phase III survival trials under the Weibull modelJianrong WuJournal of Biopharmaceutical Statistics|May 27, 2015
Assessing the impact of safety monitoring on the efficacy analysis in large Phase III group sequential trials with non-trivial safety event rateYanqiu Weng, Yuko Y Palesch, Stacia M DeSantis, et al.Journal of Biopharmaceutical Statistics|March 20, 2023
Simple methods for comparing two predictive values with incomplete dataYougui WuJournal of Biopharmaceutical Statistics|March 23, 2023
Application of estimand framework in ICH E9 (R1) to safety evaluationXuelong Wang, Ping Yang, Shuai S Yuan, et al.Journal of Biopharmaceutical Statistics|January 30, 2023
Hybrid continuous reassessment method with overdose control for safer dose escalationDebopriya Ghosh, Hong Xie, Liangcai Zhang, et al.Journal of Biopharmaceutical Statistics|February 10, 2023
A Bayesian joint model for multivariate longitudinal and time-to-event data with application to ALL maintenance studiesDamitri Kundu, Partha Sarkar, Kiranmoy DasPageof 219